The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.


Clinical Tools and Resources for Lung Cancer


The purpose of these derivative products is to more widely disseminate, in a practical and user-friendly form, the recommendations contained in the guidelines.  In the lung cancer area, ASCO currently has derivative products for a guideline on chemotherapy for stage IV non small cell lung cancer and adjuvant therapy for stages I-IIIa resectable non small cell lung cancer


Clinical Tools and Resources

Stage IV Non Small Cell Lung Cancer First Line Chemotherapy Decision Aid

Stage IV Non Small Cell Lung Cancer Second Line Chemotherapy Decision Aid

Stage IV Non Small Cell Lung Cancer Second or Third Line Chemotherapy with Erlotinib Decision Aid

Stage IV Non Small Cell Lung Cancer Third or Forth Line Chemotherapy Decision Aid

Stage IV Non Small Cell Lung Cancer All Decision Aids Set

CCO-ASCO Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Resectable Non-Small Cell Lung Cancer Decision Aid Tool for Stage IB

CCO-ASCO Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Resectable Non-Small Cell Lung Cancer Decision Aid Tool for Stage II

CCO-ASCO Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Resectable Non-Small Cell Lung Cancer Decision Aid Tool for Stage III


Journal of Oncology Practice (JOP) Guideline Summary

Chemotherapy for Stage IV Non Small Cell Lung Cancer JOP Guideline Summary (coming soon)

CCO-ASCO Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Resectable Non-Small Cell Lung Cancer JOP Guideline Summary


Summary Slide Set


Chemotherapy for Stage IV Non Small Cell Lung Cancer Slide Set (pps)

Chemotherapy for Stage IV Non Small Cell Lung Cancer Slide Set (pdf)

CCO-ASCO Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non-Small Cell Lung Cancer Slide Set (ppt)

CCO-ASCO Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non-Small Cell Lung Cancer Slide Set (pdf)


Patient Guide

Chemotherapy for Stage IV Non Small Cell Lung Cancer Patient Guide

CCO-ASCO Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non-Small Cell Lung Cancer Patient Guide


ASCO’s practice guidelines and technology assessments reflect expert consensus based on clinical evidence and literature available at the time they are written, and are intended to assist physicians in clinical decision-making and identify questions and settings for further research.  Due to the rapid flow of scientific information in oncology, new evidence may have emerged since the time a guideline or assessment was submitted for publication.  Guidelines and assessments are not continually updated and may not reflect the most recent evidence.  Guidelines and assessments cannot account for individual variation among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments.  It is the responsibility of the treating physician or other health care provider, relying on independent experience and knowledge of the patient, to determine the best course of treatment for the patient.  Accordingly, adherence to any guideline or assessment is voluntary, with the ultimate determination regarding its application to be made by the physician in light of each patient's individual circumstances.  ASCO guidelines and assessments describe the use of procedures and therapies in clinical practice and cannot be assumed to apply to the use of these interventions in the context of clinical trials. ASCO assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of ASCO’s guidelines or assessments, or to any errors or omissions.

Last Updated: 11/16/09





 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005-2009 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.